Augmedix, Inc.·3

May 4, 9:30 PM ET

RedCo II Master Fund, L.P. 3

3 · Augmedix, Inc. · Filed May 4, 2023

Insider Transaction Report

Form 3
Period: 2023-05-02
Holdings
  • Common Stock

    8,696,146
  • Pre-Funded Warrants to Purchase Common Stock

    Exercise: $0.00From: 2023-04-19Common Stock (3,125,195 underlying)
Footnotes (3)
  • [F1]Redmile Group, LLC ("Redmile") has filed a Form 4 concurrently with RedCo II Master Fund, L.P.'s ("RedCo II") filing of this Form 3 to report Redmile's indirect beneficial ownership of the Common Stock.
  • [F2]The Pre-Funded Warrants are exercisable by the holder at any time on or after the date of the securities purchase agreement between Augmedix, Inc. (the "Issuer") and certain stockholders, including RedCo II Master Fund, L.P., dated as of April 19, 2023, until fully exercised at an exercise price of $0.0001 per Pre-Funded Warrant share, subject to a limitation on the right of the Issuer to issue the Pre-Funded Warrant shares if and to the extent that such exercise would violate the rules or regulations of Nasdaq Stock Market LLC. The Pre-Funded Warrants have no expiration date.
  • [F3]Redmile filed a Form 4 on April 21, 2023 to report its indirect beneficial ownership of the Pre-Funded Warrants.

Documents

1 file
  • 3
    tm2314575-1_3seq1.xmlPrimary

    OWNERSHIP DOCUMENT